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The field of global health is evolving and moving for-
ward from not just securing open access publication to
aid in the dissemination of research but further still,
making the data underpinning the results of that publi-
cation open. Funders1 in the field, and recently the
International Committee of Medical Journal Editors
(ICMJE) [1], are increasingly requiring that researchers
make data produced during their grants publicly
accessible.
Although the push for more data sharing and transpar-
ency started with the genomics community, it is quickly
spreading to the global health communities. Indeed, two
major organisations in the field have already set up a strong
infrastructure for data reuse and sharing. Many of us are
already familiar with the power of open data through the
WHO Global Health Observatory Data Repository [2] and
the World Bank Open Data Catalogue [3], both of which
are invaluable resources. In February 2016 the Wellcome
Trust also joined ‘over 30 global health bodies in calling for
all research data gathered during the Zika virus outbreak,
and future public health emergencies, to be made available
as rapidly and openly as possible’ [4]. This follows a consen-
sus statement arising from a WHO consultation in Septem-
ber 2015 moving towards making this the global norm [5].
Reproductive Health wants to help spearhead this
paradigm shift to ensure all data underlying the research
published within the journal is publicly available to en-
sure transparency of research and contribute to enhan-
cing research in the field.Why open data?
Open Data—such as that found in the WHO Global
Health Observatory Data Repository and from the
World Bank—is especially important in the field of* Correspondence: Natasha.salaria@biomedcentral.com
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statistical power of pools of data rather than individual
datasets. We need a bird’s eye view to detect trends and
combat global epidemics.
Examples of the benefits of sharing data to global
health research exist beyond the community resources
mentioned from the WHO and World Bank. The Con-
sortium of Health-Orientated Research in Transitioning
Societies (COHORTS) study is one such example [6].
Funded by the Wellcome Trust and led by Cesar Vic-
tora, one group of researchers pooled data from 5 major
cohort studies on maternal and infant factors in low and
middle income countries. This larger pool of data pro-
vided relevant information about the relevance of the
first 1000 days of life on further quality of life and edu-
cational attainment and earnings. Pooling their data gave
the researchers enhanced statistical power and enabled
them to generate more information around the impact
on the first 1000 days of life. This example highlights
how greater data sharing through collaboration can
greatly benefit the individual researcher, leading to more
prestigious and more impactful publications.
But reuse of, and the potential for, open data is only
one of the driving factors. Also key to this conversation
around data access is transparency. Health interventions
must be driven by evidence, and that evidence must be
verifiable. Well established organisations in the global
health community have overstated the case for certain
health interventions, polarising views on the use of cer-
tain interventions. A good example is the secondary ana-
lyses of the WHO Antenatal Care trial performed by
Vogel et al. [7]. The large, cluster randomized WHO
Antenatal Care Trial concluded that a goal-orientated
package of antenatal care with reduced visits seemed not
to affect maternal and perinatal outcomes [8]. This sec-
ondary analysis of the WHO Antenatal Care Trial data
indicates that there is an appreciable increased risk of
fetal death at 32 to 36 weeks gestation for womenle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Salaria et al. Reproductive Health  (2016) 13:71 Page 2 of 2receiving the goal-oriented, reduced frequency antenatal
care package. In a Commentary regarding the publication
of this secondary analysis, Hofmeyr and Hodnett [9] con-
cluded that “this re-analysis was robust after adjustment
for potential confounding factors, and that the increase in
perinatal mortality (was) consistent with trends in the two
other cluster randomized trials conducted in Zimbabwe
[10], we find the evidence, that a reduced number of ante-
natal visits is associated with increased perinatal mortality,
compelling” [9]. Derivatives of these conclusions are of
great magnitude since the WHO Antenatal Care Trial
paper and derived publications such as the WHO manual
for the implementation of the new model (http://
www.who.int/reproductivehealth/publications/maternal_
perinatal_health/RHR_01_30/en/index.html) have im-
pacted antenatal care practice in many low-income coun-
tries. What is needed in health interventions is an
objective, depoliticized view of the evidence. That kind of
clarity comes with data transparency. Increased data ac-




In line with the above and to solidify our commitment in
ensuring research data is made publicly available, Repro-
ductive Health will be introducing a mandatory data shar-
ing policy. We will be recommending that authors publish
their data before submission in the Dataverse repository
[11], a general repository run out of Harvard which charges
no fee for storing up to 5GB of data. We also recommend
authors utilise the following checklist when planning to de-
posit their data into their chosen repository: http://mozillas-
cience.github.io/checklist/ [12].
Data notes
In addition to this policy change, Reproductive
Health has introduced a ‘Data Note’ as an article
type [13] which authors are now able to select dur-
ing submission. This article type is 3–4 pages in
length and makes datasets open ahead of research
findings being published. We have also updated the
Instructions for Authors to include a section on
‘Availability of supporting data’. If you have any
queries regarding the introduction of this new policy,
please feel free to contact the Journal Editorial Office on
reproductivehealthjournal@biomedcentral.com.
We are excited about this new chapter in Reproductive
Health and look forward to receiving your Data Notes.
Endnote
1Such funders and international organisations include,
for example, Médecins Sans Frontières/Doctors Without
Borders, WHO, Bill and Melinda Gates Foundation,Wellcome Trust, UK Medical Research Council (MRC),
US National Institutes of Health (NIH), US Centers for
Disease Control and Prevention (CDC), and others.
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